REDWOOD CITY, Calif., Feb. 8 /PRNewswire-FirstCall/ -- Genomic Health, Inc. (NASDAQ:GHDX) today announced that Kim Popovits, Genomic Health's President and Chief Operations Officer, will present at the BIO CEO & Investor Conference in New York, NY on Feb. 12, 2008 at 10:15 a.m. Eastern Time.
To access the live and subsequently archived webcast of the presentation, visit the Investor Relations section of Genomic Health's website at http://investor.genomichealth.com/. Please connect to the website at least 15 minutes prior to the beginning of the presentation to allow for any necessary software downloads. An archived replay will be available for three months after the live presentation.
About Genomic Health Genomic Health, Inc. (NASDAQ:GHDX) is a life science company focused on the development and commercialization of genomic-based clinical laboratory services for cancer that allow physicians and patients to make individualized treatment decisions. In 2004, Genomic Health launched its first test, Oncotype DX(R), which has been shown to predict the likelihood of breast cancer recurrence and the likelihood of chemotherapy benefit in a large portion of early-stage breast cancer patients. The company was founded in 2000 and is located in Redwood City, California. For more information, please visit http://www.genomichealth.com/. DATASOURCE: Genomic Health, Inc.
CONTACT: investors, Brad Cole, +1-650-569-2281, , or media, Emily Faucette, +1-650-569-2824, , both of Genomic Health, Inc.
Web site: http://www.genomichealth.com/
|